Jun Fei Feng

Direttore Finanziario/CFO presso Beijing Shenogen Pharma Group Ltd.

41 anni

Consumer Services

Electronic Technology

Health Technology

Profilo

Jun Fei Feng is currently the CFO, Board Secretary & Deputy GM at Beijing Shenogen Pharma Group Ltd.
He previously worked as a Secretary at Beijing Hanbang Technology Corp.
Mr. Feng graduated from Central University of Finance & Economics with a graduate degree in 2008 and from Northwest University of Politics & Law with an undergraduate degree in 2005.

Posizioni attive di Jun Fei Feng

Società	Posizione	Inizio
Beijing Shenogen Pharma Group Ltd. Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China.	Direttore Finanziario/CFO	01/09/2019

Tutte le posizioni attive di Jun Fei Feng

Precedenti posizioni note di Jun Fei Feng

Società	Posizione	Fine
BEIJING HANBANG TECHNOLOGY CORP.	Segretario Aziendale	-

Vedi nel dettaglio l'esperienza di Jun Fei Feng

Formazione di Jun Fei Feng

Northwest University of Politics & Law	Undergraduate Degree
Central University of Finance & Economics	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jun Fei Feng

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
BEIJING HANBANG TECHNOLOGY CORP.	Electronic Technology

Aziende private	1
Beijing Shenogen Pharma Group Ltd. Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China.	Health Technology